Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.
|Articles|March 11, 2008
NAA once again calls on FDA to remove mercury from vaccines, rethink schedule
National Autism Association holds press conference on mercury-containing vaccines and examine immunization schedule for risk.
Advertisement
A case of autism that developed after a child received nine vaccines in one day has prompted the National Autism Association (
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
An analysis found all-cause pneumonia Black, lower-income, and medically at-risk children still face substantially higher rates of hospitalization.
Thomas Lew, MD, ABIM, Molly O’Shea, MD, FAAP, and Jesse Goodman, MD, MPH, discuss vaccine policy changes and their impact on measles outbreaks.
Molly O’Shea, MD, FAAP, shares insights on MMR coverage, measles outbreaks, and the pharmacist’s role from the perspective of a pediatrician.
Observed by APhA and ASHP since 2023, bipartisan support has garnered to give pharmacy workforce suicide awareness its own federally recognized day.
Atogepant reduced migraine days during the perimenstrual period, positioning the medication as a potential first treatment option for the condition.
Chad Worz, PharmD, BCGP, FASCP, discusses the Main Street Pharmacy Access Act, a revolutionary pharmacy-focused bill moving through Congress.
Advertisement
Advertisement
Trending on Drug Topics
1
Johnson & Johnson Next Major Drugmaker to Require 340B Claims Data
2
Generic Drug Costs Burdening Patients as Much as Brand Name Options
3
How the Main Street Pharmacy Access Act Advances Pharmacist Provider Status
4
Pharmacy Workforce Suicide Awareness Day Aiming for Federal Recognition
5